Imperial Capital initiates its coverage on Diebold Incorporated DBD with a rating of Outperform and a $47 price target.
Imperial Capital comments, "We believe DBD is strongly positioned to capitalize on the financial industry's shift toward self-service transactions. We see particular growth opportunities for DBD's deposit automation solutions, with a total addressable market of over 90,000 ATMs in North America and representing a multi-year upgrade cycle globally."
DBD closed at $37.55 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in